Dashboard
Manage Tickers

AKYAAkoya Biosciences, Inc.

Nasdaq akoyabio.com


$ 2.19 $ 0.01 (0.45 %)    

Friday, 14-Jun-2024 15:55:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 2.21
$ 2.12
$ 0.00 x 0
$ 0.00 x 0
$ 2.06 - $ 2.19
$ 1.88 - $ 8.80
175,879
na
108.71M
$ 1.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-04-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-14-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-19-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

analyst-scoreboard-4-ratings-for-akoya-biosciences
Analyst Scoreboard: 4 Ratings For Akoya Bi...
06/03/2024 14:00:34

morgan-stanley-maintains-overweight-on-akoya-biosciences-lowers-price-target-to-4
Morgan Stanley Maintains Overweight on Ako...
06/03/2024 13:05:23

Morgan Stanley analyst Tejas Savant maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target ...

canaccord-genuity-maintains-buy-on-akoya-biosciences-lowers-price-target-to-6
Canaccord Genuity Maintains Buy on Akoya B...
05/14/2024 17:32:14

Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and lowers the price target from ...

why-alibaba-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Alibaba Shares Are Trading Lower By Ar...
05/14/2024 17:30:43

btig-maintains-buy-on-akoya-biosciences-lowers-price-target-to-6
BTIG Maintains Buy on Akoya Biosciences, L...
05/14/2024 17:01:49

BTIG analyst Mark Massaro maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and lowers the price target from $9 to $6.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 16:31:13

why-alcon-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket
Why Alcon Shares Are Trading Higher By Ove...
05/14/2024 12:30:32

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 12:06:42

akoya-biosciences-cuts-fy24-revenue-forecast-from-114m-118m-to-104m-112m-est-115767m
Akoya Biosciences Cuts FY24 Revenue Foreca...
05/13/2024 20:38:26

Akoya is updating its revenue outlook for the full year 2024 while maintaining its commitment to achieving operating cash flow ...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/13/2024 20:31:07

akoya-biosciences-q1-2024-adj-eps-039-misses-029-estimate-sales-18350m-miss-24281m-estimate
Akoya Biosciences Q1 2024 Adj EPS $(0.39) ...
05/13/2024 20:14:50

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $...

akoya-biosciences-and-neracare-enter-exclusive-agreement-to-enable-personalized-therapy-selection-for-early-stage-melanoma-patients
Akoya Biosciences And NeraCare Enter Exclu...
05/09/2024 13:02:28

Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory tests for ...

akoya-biosciences-and-shanghai-kr-pharmtech-announce-chinese-regulatory-agency-premarket-approval-for-kr-ht5-in-china-to-support-next-generation-pathology-clinical-workflows
Akoya Biosciences And Shanghai KR Pharmtec...
05/02/2024 12:19:37

Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing mol...

jp-morgan-maintains-overweight-on-akoya-biosciences-lowers-price-target-to-10
JP Morgan Maintains Overweight on Akoya Bi...
03/06/2024 16:06:20

JP Morgan analyst Tycho Peterson maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target fro...

ubs-maintains-buy-on-akoya-biosciences-raises-price-target-to-75
UBS Maintains Buy on Akoya Biosciences, Ra...
03/05/2024 14:44:40

UBS analyst John Sourbeer maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and raises the price target from $7 to $7.5.

canaccord-genuity-reiterates-buy-on-akoya-biosciences-maintains-10-price-target
Canaccord Genuity Reiterates Buy on Akoya ...
03/05/2024 13:58:22

Canaccord Genuity analyst Kyle Mikson reiterates Akoya Biosciences (NASDAQ:AKYA) with a Buy and maintains $10 price target.

akoya-biosciences-sees-fy24-revenue-114m-118m-vs-11738m-est
Akoya Biosciences Sees FY24 Revenue $114M-...
03/04/2024 21:40:32

2024 Financial OutlookThe Company, based on its current plans and initiatives, expects full year 2024 revenue guidance range of...

recap-akoya-biosciences-q4-earnings
Recap: Akoya Biosciences Q4 Earnings
03/04/2024 21:15:10

akoya-biosciences-q4-2023-gaap-eps-022-beats-028-estimate-sales-2649m-beat-2589m-estimate
Akoya Biosciences Q4 2023 GAAP EPS $(0.22)...
03/04/2024 21:15:05

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0...

earnings-scheduled-for-march-4-2024
Earnings Scheduled For March 4, 2024
03/04/2024 09:53:45

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)